11350396

Source:http://linkedlifedata.com/resource/pubmed/id/11350396

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002199, umls-concept:C0087111, umls-concept:C0205179, umls-concept:C0449438, umls-concept:C0521116, umls-concept:C0740457
pubmed:issue	7
pubmed:dateCreated	2001-5-14
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100886721
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1464-4096
pubmed:author	pubmed-author:GoreMM, pubmed-author:StebbingJJ
pubmed:issnType	Print
pubmed:volume	87
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	599-601
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11350396-Antineoplastic Agents, pubmed-meshheading:11350396-Carcinoma, Renal Cell, pubmed-meshheading:11350396-Clinical Trials as Topic, pubmed-meshheading:11350396-Forecasting, pubmed-meshheading:11350396-Humans, pubmed-meshheading:11350396-Interferon-alpha, pubmed-meshheading:11350396-Kidney Neoplasms, pubmed-meshheading:11350396-Quality of Life, pubmed-meshheading:11350396-Randomized Controlled Trials as Topic, pubmed-meshheading:11350396-Survival Rate
pubmed:year	2001
pubmed:articleTitle	The current status of interferon-alpha treatment in advanced renal cancer.
pubmed:affiliation	The Department of Medicine, The Royal Marsden NHS Trust, London, UK.
pubmed:publicationType	Journal Article, Review